No Data
No Data
Express News | Q32 Bio Inc Shares Hit Record Low After Guggenheim Downgrades Stock, Last Down 21.2%
Q32 Bio Is Maintained at Outperform by BMO Capital
Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday
BMO Capital Maintains Q32 Bio(QTTB.US) With Buy Rating, Cuts Target Price to $22
Guggenheim Downgrades Q32 Bio to Neutral
Q32 Bio Analyst Ratings